Impact of omega-3 PUFAs on the gut microbiome during a weight-loss intervention in women at high risk for breast cancer
Peri- and postmenopausal women (BMI>28) were enrolled in a placebo-controlled weight-loss omega-3 PUFA intervention for 6 months at the University of Kansas Medical Center. Participants with baseline and 6-month fecal samples were isolated for DNA and 12M read depth metagenomics sequencing was performed. Please see Fabian et. al., 2021 for original interventional study design.